«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:

期数:

2023年02期

页码:

195-199

栏目:

论著

出版日期:

2023-04-20

文章信息/Info

Title:

Pulmonary sarcomatoid carcinoma:a case report and review of the literature

作者:

李春艳¹ 徐剑铖² 张栎² 徐静² 胡明冬¹

400037 重庆,陆军(第三)军医大学第二附属医院老年医学科¹、呼吸与危重症医学科²

Author(s):

Li Chunyan¹;  Xu Jiancheng²;  Zhang Yue²;  Xu Jing²;  Hu Mingdong¹.

¹Department of Geriatrics Medicine Xinqiao Hospital, Army Medical University, Chongqing 400037, China; ²Institute of Respiratory Diseases, Xinqiao Hospital, Army Medical University, Chongqing 400037, China

关键词:

肺肉瘤样癌;  文献复习;  一例报道

Keywords:

Pulmonary sarcomatoid carcinoma;  Literature review;  Case report

分类号:

R734.2

DOI:

10.3877/cma.j.issn.1674-6902.2023.02.009

摘要:

目的 分析肺肉瘤样癌(pulmonary sarcomatoid carcinoma)的临床特点及诊治方案,以提高对肺肉瘤样癌的认识。方法 选择我院2021年12月1日收治的1例肺肉瘤样癌患者,行胸部CT、支气管镜活检、胸腔镜活检、B超引导下肺穿刺活检及剖胸探查,检索近10年相似病例的文献,进行分析。结果 患者胸部CT示左侧胸腔不规则片状、团片状稍低、软组织混杂密度影,增强扫描呈边缘明显强化,内容物强化不明显,左肺组织受压,其内斑片状密度增高模糊影。 胸腔镜、支气管镜及B超引导下肺穿刺活检为慢性炎症。开胸活检病理诊断为肺肉瘤样癌。结论 肺肉瘤样癌发病率低,临床表现及影像学无特异性,小标本易漏诊和误诊,诊断主要依赖于病理学。临床应考虑该病可能,早发现、早诊断、早治疗,降低病死率。

Abstract:

Objective Based on reported a case of pulmonary sarcomatoid carcinoma and reviewed the abovementioned diseases in recent years, to summarize the clinical features, diagnosis and treatment of this disease for improve the understanding of this disease. Methods Reported a case of pulmonary sarcomatoid carcinoma that we diagnosis and treatment, and retrieval of similar cases in rencent ten years in literature.Then summarizes the clinical features, diagnosis and treatment. Case: 1 months ago, the patient developed chest pain without obvious inductions, and the pain recurred, accompanied by streaks of blood in the sputum. Later, the chest pain gradually worsened. The patient was repeatedly referred to a local hospital, where tracheoscopy and thoracoscopy indicated pneumonia, and the symptoms were not significantly relieved after anti-inflammatory therapy. After being admitted to our hospital, the chest pain continued to worsen and became unbearable. Chest CT showed space occupying in the left thoracic cavity, and tracheoscopy and B-ultrasound guided puncture failed to identify the cause. Due to the progressive decline of hemoglobin, a thoracotomy was decided after multidisciplinary consultation. Results The exploratory thoracotomy was confirmed as pulmonary sarcomatoid carcinoma. Patient was not treated and leaves hospital after diagnosis. After a few days the disease progressed and the patient died at home. Conclusions The incidence of pulmonary sarcomatoid carcinoma is extremely low, The clinical and imaging manifestations of pulmonary sarcomatoid carcinoma are not specific.he diagnosis mainly depends on pathology, and is easy to be misdiagnosed as other common lung cancer. It should be paid enough attention to these diseases in clinical practice.

参考文献/References:

1 Pelosi G, Melotti F, Cavazza A, et al. A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples[J]. Anticancer Res, 2012, 32(4): 1463-1473.
2 Tamaki T, Shimizu T, Niki M, et al. Immunohistochemical analysis of NA NOG expssion and epithelial-mesenchymal transition in pulmonary sarcomatoid carcinoma[J]. Oncol Lett, 2017, 13(5): 3695-3702. doi: 10.3892/ol.2017.5864.
3 Huang SY, Shen SJ, Li XY. Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 case[J]. World J Surg Oncol, 2013, 11: 252.
4 Liang X, Cheng Y, Yuan Z, et al. Clinical, pathological and treatment factors associated with the survival of patients with pulmonary sarcomatoid carcinoma[J]. Oncol Lett, 2020, 19(6): 4031-4039.
5 Arshad HS, Dudekula RA, Niazi M, et al. A rare case of sarcomatoid[J]. Chin J Lung Cancer, 2018, 21(12): 905.
6 Karim NA, Schuster J, Eldessouki I, et al. Pulmonary sarcomatoid carcinoma: University of Cincinnati experience[J]. Oncotarget, 2018, 9(3): 4102-4108.
7 Travis WD, Brambilla E, Burke AP, et al. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart[J]. J Thorac Oncol, 2015, 10(9): 1240-1242.
8 Mansfield AS, Roden AC, Boland JM. Towards a molecular classification of pulmonary sarcomatoid carcinomas[J]. Thorac Oncol, 2017, 12(6): 910-912.
9 Ung M, Rouquette I, Filleron T, et al. Characteristics and clinical outcomes of sarcomatoid carcinoma of the lung[J]. Clin Lung Cancer, 2016, 17(5): 391-397.
10 Gounant V, Brosseau S, Naltet C, et al. Nivolumab-induced organizing pneumonitis in a patient with lung sarcomatoid carcinoma[J]. Lung Cancer, 2016, 99: 162-165.
11 Ito K, Oizumi S, Fukumoto S, et al. Clinical characteristics of pleomorphic carcinoma of the lung[J]. Lung Cancer, 2010, 68(2): 204-210.
12 Naohiro T, Tsutomu K, Takaharu I, et al. A case of synchronous double primary lung cancer presenting with pleomorphic carcinoma and adenocarcinoma[J]. Am J Case Rep, 2014, 15(3): 576-579.
13 Franks TJ, Galvin JR. Sarcomatoid carcinoma of the lung: histologic criteria and common lesions in the differential diagnosis[J]. Arch Pathol Lab Med, 2010, 134(1): 49-54.
14 Weissferdt A, Kalhor N, Correa AM, et al. Sarcomatoid carcinomas of the lung: a clinicopathological study of 86 caseswith a new perspective on tumor classification[J]. Hum Pathol, 2017, 63: 14-26.
15 Ouziane I, Boutayeb S, Mrabti H, et al. Sarcomatoid carcinoma of the lung: a model of resistance of chemotherapy[J]. N Am J Med Sci, 2014, 6(7): 342-345.
16 徐晓莉, 宋 伟, 隋 昕, 等. 原发性肺肉瘤样癌的CT表现与病理特点[J]. 中国医学科学院学报, 2016, 38(1): 93-98.
17 张新东, 张谷青, 陈月芹. 肺肉瘤样癌的CT诊断及误诊分析[J]. 医学影像学杂志, 2014(4): 531-533, 552.
18 Rapicetta C, Lococo F, Stefni A, et al. Pulmonary sarcomatoid carcinoma of the lung: Radiometabolic((18)F-FDG PET/CT)findings and correlation with clinic-pathological and survival results[J]. Lung, 2016, 194(4): 653-657.
19 Weissferdt A, Kalhor N, Rodriguezcanales J, et al. Spindle cell and pleomorphic(“sarcomatoid”)carcinomas of the lung: an immunohistochemical analysis of 86 cases[J]. Hum Pathol, 2017, 59: 1-9.
20 王丽丽, 张 静, 梁小龙, 等. 肺肉瘤样癌的临床病理特征及分子特点研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2017, 10(1): 83-86.
21 Litzky LA. Pulmonary sarcomatous tumors[J]. Arch Pathol Lab Med, 2008, 132(7): 1104-1117.
22 Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Sinc e the 2004 Classification[J]. J Thorac Oncol, 2015, 10(9): 1243-1260.
23 刘 雷, 臧若川, 宋 朋, 等. 肺肉瘤样癌的诊治现状[J]. 中国肺肿瘤杂志, 2018, 21(12): 902-906.
24 Zeng Q, Li J, Sun N, et al. “Preoperative systemic immune inflammation index predicts survival and recurrence in patients with resected primary pulmonary sarcomatoid carcinoma”[J]. Translational Lung Cancer Research, 2021, 10(1): 18-31.
25 Lin Y, Yang H, Cai Q, et al. Characteristics and prognostic analysis of 69 patients with pulmonary sarcomatoid carcinoma[J]. Am J Clin Oncol, 2016, 39(3): 215-222.
26 Terra SB, Jang JS, Bi L, et al. Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases[J]. Mod Pathol, 2016, 29: 824-831.
27 Forest F, Yvorel V, Karpathiou G, et al. Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies[J]. Hum Pathol, 2016, 49: 99-106.
28 Maneenil K, Xue Z, Liu M, et al. Sarcomatoid carcinoma of the lung: the Mayo clinic experience in 127 patients[J]. Clin Lung Cancer, 2018, 19: e323-e333.
29 Velcheti V, Rimm DL, Schalper KA. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1(PD-L1)[J]. J Thorac Oncol, 2013, 8: 803-805.
30 Tunger A, Sommer U, Wehner R, et al. The evolving landscape of biomarkers for anti-PD-1 or anti-PD-L1 therapy[J]. J Clin Med, 2019, 8: 1534.
31 Zhou F, Huang Y, Cai W, et al. The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients[J]. Lung Cancer, 2021, 153: 66-72.
32 Vieira T, Antoine M, Ruppert AM, et al. Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung[J]. Lung Cancer, 2014, 85: 276-281.
33 Vieira T, Girard N, Ung M, et al. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma[J]. J Thorac Oncol, 2013, 8: 1574-1577.

备注/Memo

备注/Memo:

基金项目: 国家科技部重点研发计划(2020YFC2008900,2020YFC2008903)
通信作者: 徐 静, Email: physicianxj@163.com
胡明冬, Email: humingdong@tmmu.edu.cn

常用功能

更新日期/Last Update: 2023-04-20